# Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section

Study · id `cardio:ct-nct04069078` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04069078](<https://clinicaltrials.gov/study/NCT04069078>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04069078

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 173 participants.

## Technical summary

Registry record NCT04069078. Randomized; triple masking; primary purpose prevention. Start 2019-10-10 (actual); primary completion 2020-02-25 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 173 participants (enrolled count; ClinicalTrials.gov record NCT04069078, source copy `cardio:ctgov-nct04069078-2020-03-03`, retrieved 2026-10-26)
- Started: 2019-10-10 (actual) (ClinicalTrials.gov record NCT04069078, source copy `cardio:ctgov-nct04069078-2020-03-03`, retrieved 2026-10-26)
- Primary completion: 2020-02-25 (actual) (ClinicalTrials.gov record NCT04069078, source copy `cardio:ctgov-nct04069078-2020-03-03`, retrieved 2026-10-26)
- Completion: 2020-02-25 (actual) (ClinicalTrials.gov record NCT04069078, source copy `cardio:ctgov-nct04069078-2020-03-03`, retrieved 2026-10-26)
- Countries: Egypt (ClinicalTrials.gov record NCT04069078, source copy `cardio:ctgov-nct04069078-2020-03-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04069078-2020-03-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section
- Condition: Bradycardia
- Condition: Spinal Anesthetics Causing Adverse Effects in Therapeutic Use
- Condition: Cesarean Section Complications
- Intervention (Drug): Hyoscine Butylbromide 20 Mg/mL Solution for Injection Ampoule
- Intervention (Other): Normal saline
- Lead sponsor: Assiut University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Bradycardia (`cardio:bradycardia`)
- Registry lists this organization as the lead sponsor: Assiut University (`cardio:org-assiut-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Hemodynamic and antiemetic effects of prophylactic hyoscine butyl-bromide during cesarean section under spinal anesthesia: a randomized controlled trial (`cardio:pubmed-35448942`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: da3c1c5d99f1e3b2656c5eae0b5a18843fc4c1ad2d16d53584f4282ea1153aef
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
